Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 347

1.

Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.

Luo Z, Hu Y, Cai K, Ding X, Zhang Q, Li M, Ma X, Zhang B, Zeng Y, Li P, Li J, Liu J, Zhao Y.

Biomaterials. 2014 Sep;35(27):7951-62. doi: 10.1016/j.biomaterials.2014.05.058. Epub 2014 Jun 13.

PMID:
24930850
2.

Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.

Liu J, Luo Z, Zhang J, Luo T, Zhou J, Zhao X, Cai K.

Biomaterials. 2016 Mar;83:51-65. doi: 10.1016/j.biomaterials.2016.01.008. Epub 2016 Jan 6.

PMID:
26773665
3.

Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.

Zhang B, Luo Z, Liu J, Ding X, Li J, Cai K.

J Control Release. 2014 Oct 28;192:192-201. doi: 10.1016/j.jconrel.2014.06.037. Epub 2014 Jul 15.

PMID:
25034575
4.

Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs.

Kwon S, Singh RK, Kim TH, Patel KD, Kim JJ, Chrzanowski W, Kim HW.

Acta Biomater. 2014 Mar;10(3):1431-42. doi: 10.1016/j.actbio.2013.10.028. Epub 2013 Nov 15.

PMID:
24239681
5.

Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.

Dai L, Li J, Zhang B, Liu J, Luo Z, Cai K.

Langmuir. 2014 Jul 8;30(26):7867-77. doi: 10.1021/la501924p. Epub 2014 Jun 23.

PMID:
24933090
6.

Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo.

Luo Z, Ding X, Hu Y, Wu S, Xiang Y, Zeng Y, Zhang B, Yan H, Zhang H, Zhu L, Liu J, Li J, Cai K, Zhao Y.

ACS Nano. 2013 Nov 26;7(11):10271-84. doi: 10.1021/nn404676w. Epub 2013 Oct 21.

PMID:
24127723
7.

Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.

Zou Z, He D, He X, Wang K, Yang X, Qing Z, Zhou Q.

Langmuir. 2013 Oct 15;29(41):12804-10. doi: 10.1021/la4022646. Epub 2013 Oct 3.

PMID:
24073830
8.

Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.

Ma X, Teh C, Zhang Q, Borah P, Choong C, Korzh V, Zhao Y.

Antioxid Redox Signal. 2014 Aug 10;21(5):707-22. doi: 10.1089/ars.2012.5076. Epub 2013 Sep 28.

PMID:
23931896
9.

Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.

Ma X, Zhao Y, Ng KW, Zhao Y.

Chemistry. 2013 Nov 11;19(46):15593-603. doi: 10.1002/chem.201302736. Epub 2013 Oct 2.

PMID:
24123533
10.

Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.

Lv S, Li M, Tang Z, Song W, Sun H, Liu H, Chen X.

Acta Biomater. 2013 Dec;9(12):9330-42. doi: 10.1016/j.actbio.2013.08.015. Epub 2013 Aug 17.

PMID:
23958784
11.

Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.

She X, Chen L, Velleman L, Li C, Zhu H, He C, Wang T, Shigdar S, Duan W, Kong L.

J Colloid Interface Sci. 2015 May 1;445:151-60. doi: 10.1016/j.jcis.2014.12.053. Epub 2014 Dec 25.

PMID:
25617610
12.

Redox-responsive molecular nanoreservoirs for controlled intracellular anticancer drug delivery based on magnetic nanoparticles.

Luo Z, Cai K, Hu Y, Li J, Ding X, Zhang B, Xu D, Yang W, Liu P.

Adv Mater. 2012 Jan 17;24(3):431-5. doi: 10.1002/adma.201103458. Epub 2011 Dec 19.

PMID:
22180323
13.

Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects.

Gao F, Li L, Liu T, Hao N, Liu H, Tan L, Li H, Huang X, Peng B, Yan C, Yang L, Wu X, Chen D, Tang F.

Nanoscale. 2012 Jun 7;4(11):3365-72. doi: 10.1039/c2nr12094a. Epub 2012 Apr 27.

PMID:
22538830
14.

A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery.

Xiao D, Jia HZ, Zhang J, Liu CW, Zhuo RX, Zhang XZ.

Small. 2014 Feb 12;10(3):591-8. doi: 10.1002/smll.201301926. Epub 2013 Sep 17.

PMID:
24106109
15.

Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery.

Luo Z, Cai K, Hu Y, Zhao L, Liu P, Duan L, Yang W.

Angew Chem Int Ed Engl. 2011 Jan 17;50(3):640-3. doi: 10.1002/anie.201005061. Epub 2010 Dec 9. No abstract available.

PMID:
21226142
16.

Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.

Cheng YJ, Luo GF, Zhu JY, Xu XD, Zeng X, Cheng DB, Li YM, Wu Y, Zhang XZ, Zhuo RX, He F.

ACS Appl Mater Interfaces. 2015 May 6;7(17):9078-87. doi: 10.1021/acsami.5b00752. Epub 2015 Apr 24.

PMID:
25893819
17.

Polymeric Prodrug Grafted Hollow Mesoporous Silica Nanoparticles Encapsulating Near-Infrared Absorbing Dye for Potent Combined Photothermal-Chemotherapy.

Zhang Y, Ang CY, Li M, Tan SY, Qu Q, Zhao Y.

ACS Appl Mater Interfaces. 2016 Mar 23;8(11):6869-79. doi: 10.1021/acsami.6b00376. Epub 2016 Mar 9.

PMID:
26937591
18.

Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.

Chen L, She X, Wang T, He L, Shigdar S, Duan W, Kong L.

Nanoscale. 2015 Sep 7;7(33):14080-92. doi: 10.1039/c5nr03527a.

PMID:
26242620
19.

Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity.

Luo Z, Cai K, Hu Y, Zhang B, Xu D.

Adv Healthc Mater. 2012 May;1(3):321-5. doi: 10.1002/adhm.201100030. Epub 2012 Mar 27.

PMID:
23184747
20.

Synergism through combination of chemotherapy and oxidative stress-induced autophagy in A549 lung cancer cells using redox-responsive nanohybrids: a new strategy for cancer therapy.

Lu HY, Chang YJ, Fan NC, Wang LS, Lai NC, Yang CM, Wu LC, Ho JA.

Biomaterials. 2015 Feb;42:30-41. doi: 10.1016/j.biomaterials.2014.11.029. Epub 2014 Dec 12.

PMID:
25542791

Supplemental Content

Support Center